SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.
Bizzotto J, Sanchis P, Abbate M, Lage-Vickers S, Lavignolle R, Toro A, Olszevicki S, Sabater A, Cascardo F, Vazquez E, Cotignola J, Gueron G.
Bizzotto J, et al. Among authors: cascardo f.
iScience. 2020 Oct 23;23(10):101585. doi: 10.1016/j.isci.2020.101585. Epub 2020 Sep 23.
iScience. 2020.
PMID: 32989429
Free PMC article.